Will GE fall behind rivals in bid to dominate healthcare industry?
This article was originally published in Clinica
After Siemens succeeded in pulling off two IVD acquisitions in the form of Bayer Diagnostics and DPC last year, little surprise that imaging rival GE came up with a deal to match in January when it said it was acquiring Abbott's lab diagnostics and point-of-care businesses for $8.1bn.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.